On the other hand, our results showed that ACE2 rs2285666 GA genotype carriers were unlikely to develop fatigue, headache, loss of smell, and dyspnea, indicating the association of the minor allele A with less severity of COVID-19. This evidence concerns the gene ACE2 and COVID-19.